ResMed Inc. — Financial Statements & Ratios

RMD

NYSEHealthcareMedical - Instruments & SuppliesCIK 0000943819resmed.comAbout RMD

Last close · Oct 16, 2026238.97−3.26 (−1.35%)

Market cap$33.6B

Key indicators

Revenue5.7BFY2026+9.9% on a year earlier+11.7% a year, FY2019–FY2026

2.6B

3.0B

3.2B

3.6B

4.2B

4.7B

5.1B

5.7B

5.8B

6.2B

6.6B

Fiscal year

FY201919

FY202020

FY202121

FY202222

FY202323

FY202424

FY202525

FY202626

FY2027E27E

FY2028E28E

FY2029E29E

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	FY2027E	FY2028E	FY2029E
Growth
	2.6B	3.0B+13.4%	3.2B+8.1%	3.6B+11.9%	4.2B+18.0%	4.7B+10.9%	5.1B+9.8%	5.7B+9.9%	5.8B	6.2B	6.6B
	—	13.4%	8.1%	11.9%	18.0%	10.9%	9.8%	9.9%	2.8%	6.4%	6.4%
	$2.80	$4.27+52.5%	$3.24−24.1%	$5.30+63.6%	$6.09+14.9%	$6.92+13.6%	$9.51+37.4%	$10.43+9.7%	$12.10	$13.30	$14.56
Profitability
	58.9%	58.1%−0.9 pt	57.5%−0.6 pt	56.6%−1.0 pt	55.8%−0.8 pt	56.7%+0.9 pt	59.4%+2.7 pt	61.1%+1.7 pt	·	·	·
	22.2%	27.4%+5.2 pt	28.3%+0.9 pt	28.0%−0.3 pt	26.8%−1.2 pt	28.2%+1.4 pt	32.7%+4.6 pt	33.4%+0.6 pt	·	·	·
	15.5%	21.0%+5.5 pt	14.8%−6.2 pt	21.8%+6.9 pt	21.3%−0.5 pt	21.8%+0.5 pt	27.2%+5.4 pt	26.9%−0.3 pt	·	·	·
	19.5%	24.9%+5.4 pt	16.4%−8.5 pt	23.2%+6.7 pt	21.7%−1.5 pt	21.0%−0.7 pt	23.5%+2.5 pt	23.1%−0.3 pt	·	·	·
Cash
	390.3M	706.9M+81.1%	634.0M−10.3%	216.3M−65.9%	573.6M+165.2%	1.3B+126.9%	1.7B+27.6%	1.6B−0.7%	·	·	·
	15.0%	23.9%+8.9 pt	19.8%−4.1 pt	6.0%−13.8 pt	13.6%+7.5 pt	27.8%+14.2 pt	32.3%+4.5 pt	29.2%−3.1 pt	·	·	·
	211.7M	225.1M+6.3%	226.7M+0.7%	245.3M+8.2%	258.3M+5.3%	282.3M+9.3%	310.9M+10.1%	349.7M+12.5%	·	·	·
Balance sheet
	0.61x	0.47x−0.14x	0.23x−0.24x	0.23x+0.00x	0.35x+0.12x	0.15x−0.20x	0.11x−0.03x	0.10x−0.01x	·	·	·
	144.48M	145.65M+0.8%	146.45M+0.5%	147.04M+0.4%	147.46M+0.3%	147.55M+0.1%	147.34M−0.1%	146.05M−0.9%	·	·	·

E = analyst consensus (revenue and EPS only). From the 10-K, as accepted by the SEC; the shaded column is the latest period.